Mebendazole-d3

• CAT Number: R047486
• CAS Number: 1173021-87-8
• Molecular Formula: C16H13N3O3
• Molecular Weight: 298.316
• Purity: ≥95%
• Synonyms: N-(6-Benzoyl-1H-benzimidazol-2-yl)carbamic Acid-d8 Methyl Ester;?5-Benzoyl-2-benzimidazolecarbamic Acid-d8 Methyl Ester; Bantenol-d8; Besantin; Mebenvet-d8; Mebex-d8; Noverme-d8; Ovitelmin-d8; Pantelmin-d8; R 17635-d8
• Target: Anti-infection
• Storage: -20°C
• IUPAC Name: trideuteriomethyl N-(6-benzoyl-1H-benzimidazol-2-yl)carbamate
• InChI: InChI=1S/C16H13N3O3/c1-22-16(21)19-15-17-12-8-7-11(9-13(12)18-15)14(20)10-5-3-2-4-6-10/h2-9H,1H3,(H2,17,18,19,21)/i1D3
• InChIKey: OPXLLQIJSORQAM-FIBGUPNXSA-N
• SMILES: [2H]C([2H])([2H])OC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3

Mebendazole-d3 is a deuterated form of the antiparasitic drug mebendazole, where three hydrogen atoms have been replaced by deuterium. This isotopically labeled compound is used in pharmaceutical research, particularly in pharmacokinetic studies, to track and analyze the drug’s metabolism and distribution within the body. The incorporation of deuterium enhances the stability and precision of analytical methods such as mass spectrometry, leading to more accurate measurements of the drug’s behavior. Mebendazole-d3 is an essential tool for researchers involved in the development of antiparasitic therapies, enabling detailed investigations into the drug’s efficacy, safety, and metabolic pathways.